Alltrna
PrivateLast Round
Series B
Aug 9, 2023
Total Funding Raised
$109M
Company Overview
Alltrna is a biotechnology company that develops a tRNA platform leveraging artificial intelligence and machine learning to advance therapeutics for disease treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alltrna Comparables
Compare Alltrna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tevard Biosciences | 88% | |
| Codone Biotechnology | 85% | |
| Shape Therapeutics | 83% | |
Alltrna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 9, 2023 | ||||
| VC Round | Nov 9, 2021 |
Key People
Founding team and executive leadership
Alltrna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
David Hava appointed to lead tRNA medicines pipeline strategy.
- Jan 6, 2025
Dr. Nerissa Kreher appointed as the new Chief Medical Officer.
Alltrna Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alltrna's valuation, stock price, and market status.